Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

NYSE: More New Closing Highs Achieved

Published 02/21/2017, 08:44 AM
Updated 07/09/2023, 06:31 AM

NYSE Internals Negative

Opinion: The indexes closed mixed Friday with negative internals on the NYSE and positive internals on the NASDAQ. Volumes declined on both exchanges from the prior session. Several new closing highs were achieved on the charts that remain positive. However, the data remains a mixed bag. Nonetheless, there is not yet enough evidence being presented to warrant a shift in our near term “neutral/positive” outlook for the major equity indexes although forward valuation of the SPX and investment advisor sentiment both suggest an elevated level of risk is present.

· On the charts, the indexes closed mixed Friday with the SPX (page 2), DJI (page 2), COMPQX (page 3) and MID (page 4) all making new closing highs. The DJT also advanced but was unable to make a new high while the RTY (page 4) and VALUA (page 5) declined on the day. All of the short term uptrends remain intact. We would note, however, that the advances on the large cap indexes occurred with negative internals. While this narrowing of breadth is not conclusive of more concern of weakening internals, it is worthy of note, in our opinion.

· The data is mixed with most of the McClellan OB/OS Oscillators neutral (All Exchange:+24.13/+49.42 NYSE:+3.11/+67.09 NASDAQ:+36.1/+46.62). Only the NSYE 21 day is overbought. The Equity Put/Call Ratio is a neutral 0.59 along with a 9.9 Gambill Insider Buy/Sell Ratio. On the bullish side, the pros are very heavy calls via the OEX Put/Call Ratio at 0.44 as they continue to expect further near term strength.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

· Yet in spite of the charts and data, we continue to be of the opinion that a respectable degree of risk exists at this point in time as the forward valuation of the SPX based on forward 12 month IBES earnings estimates is at a 12 year high of a 17.8 multiple while investment advisors continue to display a disregard for any market concern as seen by the Investors Intelligence Bear Bull Ratio (contrary indicator) at 17.6/61.8. Such high valuation combined with complacency has, in the past, resulted in sudden and sharp market declines when a catalyst is triggered.

· In conclusion, although we do have some real concerns for the markets as noted above, the charts and data have yet to suggest a shift in our near term “neutral/positive” outlook for the major indexes should be entertained.

· Forward 12 month earnings estimates for the SPX from IBES of $132.33 leave a 5.63 forward earnings yield on a 17.8 forward multiple, a decade high.


SPX: 2,277/NA
DJI: 19,946/NA
COMPQX; 5,576/NA
DJT: 9,141/NA
MID: 1,697/NA
RTY: 1,377/1,357
VALUA: 5,387/NA

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.